Immunomodulatory effects of fluoxetine: A new potential pharmacological action for a classic antidepressant drug?

Pharmacological Research

Volumn 109, Issue , 2016, Pages 101-107

  Di Rosso, María Emilia ^a   Palumbo, María Laura ^b   Genaro, Ana María ^a,c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

^b Universidad Nacional del Noroeste de la Provincia de Buenos Aires   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antidepressant; Fluoxetine; Immune system; Immunomodulation; Serotonin

Indexed keywords

FLUOXETINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 7 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ANTIDEPRESSANT AGENT; IMMUNOLOGIC FACTOR;

B LYMPHOCYTE; BURKITT LYMPHOMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL POLARITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL; ANIMAL; DRUG EFFECTS; HOMEOSTASIS; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; FLUOXETINE; HOMEOSTASIS; HUMANS; IMMUNOLOGIC FACTORS; SEROTONIN;

EID: 84950107956     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.11.021     Document Type: Review

References (79)

1. J.C. Jackson, R.J. Cross, R.F. Walker, W.R. Markesbery, and W.H. Brooks Influence of serotonin on the immune response Immunology 54 1985 505 512
2. E.M. Sternberg, J. Trial, and C.W. Parker Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists J. Immunol. 137 1986 276 282
3. R. Mossner, and K.P. Lesch Role of serotonin in the immune system and in neuroimmune interactions Brain Behav. Immun. 12 1998 249 271
4. T.C. Pellegrino, and B.M. Bayer Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity requires endogenous serotonin release Neuroimmunomodulation 8 2000 179 187
5. J.A. Moynihan, and F.M. Santiago Brain behavior and immunity: twenty years of T cells Brain Behav. Immun. 21 2007 872 880
6. M. Urbina, S. Pineda, L. Piñango, I. Carreira, and L. Lima [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine Int. J. Immunopharmacol. 21 1999 631 646
7. L. Lima, S. Mata, and M. Urbina Allelic isophorms and decrease of serotonin transporter mRNA in lymphocytes of major depression patients Neuroimmunomodulation 12 2005 299 306
8. G. Resler, R. Lavie, J. Campos, S. Mata, M. Urbina, A. García, R. Apitz, and L. Lima Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes Neuroimmunomodulation 15 2008 145 152
9. E. Pallinger, and G. Csaba Effect of serotonin-acting agents on the serotonin content of immune cells. A peculiar observation Cell Biochem. Funct. 25 2007 581 583
10. P.J. O'Connell, X. Wang, M. Leon-Ponte, C. Griffiths, S.C. Pingle, and G.P. Ahern A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells Blood 107 2006 1010 1017
11. J.E. Duffy-Whritenoura, and J.T. Zelikoff Relationship between serotonin and the immune system in a teleost model Brain Behav. Immun. 22 2008 257 264
12. T. Müller, T. Dürk, B. Blumenthal, M. Grimm, S. Cicko, E. Panther, S. Sorichter, Y. Herouy, F. Di Virgilio, D. Ferrari, J. Norgauer, and M. Idzko 5-Hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo PLoS One 4 2009 e6453
13. R. Arreola, E. Becerril-Villanueva, C. Cruz-Fuentes, M.A. Velasco-Velázquez, M.E. Garcés-Alvarez, G. Hurtado-Alvarado, S. Quintero-Fabian, and L. Pavón Immunomodulatory effects mediated by serotonin J. Immunol. Res. 2015 354957 http://dx.doi.org/10.1155/2015/
14. M. Noda, H. Higashida, S. Aoki, and K. Wada Multiple signal transduction pathways mediated by 5-HT receptors Mol. Neurobiol. 29 2004 31 40
15. N.M. Barnes, and J. Gordon Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations Semin. Cancer Biol. 18 2008 218 225
16. J. Stefulj, B. Jernej, L. Cicin-Sain, I. Rinner, and K. Schauenstein mRNA expression of serotonin receptors in cells of the immune tissues of the rat Brain Behav. Immun. 14 2000 219 224
17. M. Abdouh, J.M. Storring, M. Riad, Y. Paquette, P.R. Albert, E. Drobetsky, and E. Kouassi Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes J. Biol. Chem. 276 2001 4382 4388
18. K. Iken, S. Chheng, A. Fargin, A.C. Goulet, and E. Kouassi Serotonin up-regulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors Cell Immunol. 163 1995 1 9
19. J. Yin, R.H. Albert, A.P. Tretiakova, and B.A. Jameson 5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes J. Neuroimmunol. 181 2006 68 81
20. T. Sempere, M. Urbina, and L. Lima 5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes Neuroimmunomodulation 11 2004 307 315
21. M. Abdouh, P.R. Albert, E. Drobetsky, J.G. Filep, and E. Kouassi 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-kappaB to the nucleus Brain Behav. Immun. 18 2004 24 34
22. A. González, F. Fazzino, M. Castillo, S. Mata, and L. Lima Serotonin, 5-HT1A serotonin receptors and proliferation of lymphocytes in major depression patients Neuroimmunomodulation 14 2007 8 15
23. M. Levite Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors Curr. Opin. Pharmacol. 8 2008 460 471
24. I. Cloez-Tayarani, A.F. Petit-Bertron, H.D. Venters, and J.M. Cavaillon Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine 2A receptors Int. Immunol. 15 2003 233 240
25. T. Dürk, E. Panther, T. Müller, S. Sorichter, D. Ferrari, C. Pizzirani, F. Di Virgilio, D. Myrtek, J. Norgauer, and M. Idzko 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes Int. Immunol. 17 2005 599 606
26. M. Idzko, E. Panther, C. Stratz, T. Müller, H. Bayer, G. Zissel, T. Dürk, S. Sorichter, F. Di Virgilio, M. Geissler, B. Fiebich, Y. Herouy, P. Elsner, J. Norgauer, and D. Ferrari The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release J. Immunol. 172 2004 6011 6019
27. A. Rinaldi, A.M. Chiaravalli, M. Mian, E. Zucca, M.G. Tibiletti, C. Capella, and F. Bertoni Serotonin receptor 3A expression in normal and neoplastic B cells Pathobiology 77 2010 129 135
28. B.L. Fiebich, R.S. Akundi, M. Seidel, V. Geyer, U. Haus, W. Müller, T. Stratz, and E. Candelario-Jalil Expression of 5-HT3A receptors in cells of the immune system Scand. J. Rheumatol. Suppl. 119 2004 9 11
29. B.L. Fiebich, R.S. Akundi, K. Lieb, E. Candelario-Jalil, D. Gmeiner, U. Haus, W. Müller, T. Stratz, and E. Muñoz Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide estimulated primary human monocytes Scand. J. Rheumatol. Suppl. 119 2004 28 32
30. C. Stratz, H.S. Bhatia, R.S. Akundi, T. Nührenberg, D. Trenk, E. Muñoz, and B.L. Fiebich The anti-inflammatory effects of the 5-HT3 receptor antagonist tropisetron are mediated by the inhibition of p38 MAPK activation in primary human monocytes Int. Immunopharmacol. 13 2012 398 402
31. B.A. Faraj, Z.L. Olkowski, and R.T. Jackson Expression of a high-affinity serotonin transporter in human lymphocytes Int. J. Immunopharmacol. 16 1994 561 567
32. D. Marazziti, A. Rossi, G. Giannaccini, S. Baroni, A. Lucacchini, and G.B. Cassano Presence and characterization of the serotonin transporter in human resting lymphocytes Neuropsychopharmacology 19 1998 154 159
33. F. Ferriere, N.A. Khan, J.P. Meyniel, and P. Deschaux Characterization of serotonin transport mechanisms in rainbow trout peripheral blood lymphocytes: role in PHA-induced lymphoproliferation Dev. Comp. Immunol. 23 1999 37 50
34. O. Morikawa, N. Sakai, H. Obara, and N. Saito Effects of interferon-alpha, interferon gamma and cAMP on the transcriptional regulation of the serotonin transporter Eur. J. Pharmacol. 348 1998 317 324
35. R. Mössner, A. Heils, G. Stöber, O. Okladnova, S. Daniel, and K.P. Lesch Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6 Neurochem. Int. 33 1998 251 254
36. R. Mössner, S. Daniel, A. Schmitt, D. Albert, and K.P. Lesch Modulation of serotonin transporter function by interleukin-4 Life Sci. 68 2001 873 880
37. S. Ramamoorthy, J.D. Ramamoorthy, P. Pradad, G.K. Blat, and V.B. Mahesh Regulation of the human serotonin transporter by interleukin-I beta Biochem. Biophys. Res. Commun. 216 1995 560 567
38. M. Kubera, V. Holan, R. Mathison, and M. Maes The effect of repeated amitriptyline and desimipramine administration on cytokine release in C57BL/6 mice Psychoneuroendocrinology 25 2000 785 797
39. J. Gordon, and N.M. Barnes Lymphocytes transport serotonin and dopamine: agony or ecstasy? Trends Immunol. 24 2000 438 443
40. D.J. Walther, J.U. Peter, S. Winter, M. Höltje, N. Paulmann, M. Grohmann, J. Vowinckel, V. Alamo-Bethencourt, C.S. Wilhelm, G. Ahnert-Hilger, and M. Bader Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release Cell 115 2003 851 862
41. C. Guilluy, M. Rolli-Derkinderen, P.L. Tharaux, G. Melino, P. Pacaud, and G. Loirand Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells J. Biol. Chem. 282 2007 2918 2928
42. J.P. Roiser, J. Levy, S.J. Fromm, A.C. Nugent, S.L. Talagala, G. Hasler, F.A. Henn, B.J. Sahakian, and W.C. Drevets The effects of tryptophan depletion on neural responses to emotional words in remitted depression Biol. Psychiatry 66 2009 441 450
43. J.P. Kambeitz, and O.D. Howes The serotonin transporter in depression: meta-analysis of in vivo and post mortem findings and implications for understanding and treating depression J. Affect. Disord. 186 2015 358 366
44. S. Peña, E. Baccichet, M. Urbina, I. Carreira, and L. Lima Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients Int. Immunopharmacol. 5 2005 1069 1076
45. J. Iga, S. Ueno, K. Yamauchi, I. Motoki, S. Tayoshi, K. Ohta, H. Song, K. Morita, K. Rokutan, and T. Ohmori Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine Neurosci. Lett. 389 2005 12 16
46. N. Müller, E. Hofschuster, M. Ackenheil, W. Mempel, and R. Eckstein Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis Prog. Neuropsychopharmacol. Biol. Psychiatry 17 1993 713 730
47. A. Anesi, D. Franciotta, E. Di Paolo, E. Zardini, G.V. Melzi d'Eril, and F. Zerbi PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders Funct. Neurol. 9 1994 17 22
48. M.D. Zaharia, A.V. Ravindran, J. Griffiths, Z. Merali, and H. Anisman Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features J. Affect. Disord. 58 2000 1 10
49. C. Mizrahi, A. Stojanovic, M. Urbina, and L. Lima Differential cAMP levels and serotonin receptors in blood peripheral monocytes and lymphocytes of major depression patients Int. Inmunopharmacol. 4 2004 1125 1133
50. E.P. Zorrilla, L. Luborsky, J.R. McKay, R. Rosenthal, A. Houldin, A. Tax, R. McCorkie, D.A. Seligman, and K. Schmidt The relationship of depression and stressors to immunological assays: a meta-analytic review Brain Behav. Immun. 15 2001 199 226
51. L. Pavon, G. Sandoval-Lopez, M. Eugenia Hernández, F. Loria, I. Estrada, M. Pérez, J. Moreno, U. Avila, P. Leff, B. Antón, and G. Heinze The cytokine response in major depressive disorder patients before treatment J. Neuroimmunol. 172 2006 156 165
52. F. Fazzino, C. Montes, M. Urbina, I. Carreira, and L. Lima Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation J. Neuroimmunol. 196 2008 173 180
53. J. Eugen-Olsen, P. Afzelius, L. Andresen, J. Iversen, G. Kronborg, P. Aabech, J.O. Nielsen, and B. Hofmann Serotonin modulates immune function in T cells from HIV-seropositive subjects Clin. Immunol. Immunopathol. 84 1997 115 121
54. B. Manéglier, G.J. Guillemin, P. Clayette, C. Rogez-Kreuz, B.J. Brew, D. Dormont, C. Advenier, P. Therond, and O. Spreux-Varoquau Serotonindecreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors Br. J. Pharmacol. 154 2008 174 182
55. A. Frobe, L. Cicin-Sain, G. Jones, Ž. Soldič, J. Lukač, A. Bolanča, and Z. Kusič Plasma free serotonin is a marker for early detection of breast cancer recurrence Anticancer Res. 34 2014 1167 1169
56. A. Serafeim, G. Grafton, A. Chamba, C.D. Gregory, R.D. Blakely, N.G. Bowery, N.M. Barnes, and J. Gordon Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors Blood 99 2002 2545 2553
57. A. Serafeim, M.J. Holder, G. Grafton, A. Chamba, M.T. Drayson, Q.T. Luong, C.M. Bunce, C.D. Gregory, N.M. Barnes, and J. Gordon Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells Blood 101 2003 3212 3219
58. T.C. Pellegrino, and B.M. Bayer Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity Brain Behav. Immun. 16 2002 87 103
59. T.C. Pellegrino, and B.M. Bayer Modulation of immune cell function following fluoxetine administration in rats Pharmacol. Biochem. Behav. 59 1998 151 157
60. A. Służewska, J.K. Rybakowski, M. Laciak, A. Mackiewicz, M. Sobieska, and K. Wiktorowicz Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann. N. Y. Acad. Sci. 762 1995 474 476
61. C. Song, U. Halbreich, C. Han, B.E. Leonard, and H. Luo Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment Pharmacopsychiatry 42 2009 182 188
62. M. Maes, J. Delange, R. Ranjan, H.Y. Meltzer, R. Desnyder, W. Cooremans, and S. Scharpé Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs Psychiatry Res. 66 1997 1 11
63. L.R. Frick, M.L. Palumbo, M.P. Zappia, M.A. Brocco, G.A. Cremaschi, and A.M. Genaro Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T cell response by serotonin dependent and independent mechanisms Biochem. Pharmacol. 75 2008 1817 1826
64. F. Fazzino, M. Urbina, N. Cedeño, and L. Lima Fluoxetine treatment to rats modifies serotonin transporter and cAMP in lymphocytes, CD4+ and CD8+ subpopulations and interleukins 2 and 4 Int. Immunopharmacol. 9 2009 463 467
65. M.J. Nunez, J. Balboa, E. Rodrigo, J. Brenlla, M. Gonzalez-Peteiro, and M. Freire-Garabal Effects of fluoxetine on cellular immune response in stressed mice Neurosci. Lett. 396 2006 247 251
66. V.A. Edgar, G.A. Cremaschi, L. Sterin-Borda, and A.M. Genaro Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine Brain Behav. Immun. 16 2002 333 350
67. L.R. Frick, M. Rapanelli, G.A. Cremaschi, and A.M. Genaro Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms Brain Behav. Immun. 23 2009 36 40
68. M. Freire-Garabal, M.J. Núñez, P. Riveiro, J. Balboa, P. López, B.G. Zamorano, E. Rodrigo, and M. Rey-Méndez Effects of fluoxetine on the activity of phagocytosis in stressed mice Life Sci. 72 2002 173 183
69. V.A. Edgar, L. Sterin-Borda, G.A. Cremaschi, and A.M. Genaro Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation Eur. J. Pharmacol. 372 1999 65 73
70. V.A. Edgar, A.M. Genaro, G. Cremaschi, and L. Sterin-Borda Fluoxetine action on murine T-lymphocyte proliferation: participation of PKC activation and calcium mobilisation Cell. Signal. 10 1998 721 726
71. M.B. Berkeley, S. Daussin, M.C. Hernández, and B.M. Bayer In vitro effect of cocaine, lidocaine and monoamine uptake inhibitors on lymphocyte proliferative responses Immunopharmacol. Immunotoxicol. 16 1994 165 178
72. M. Kubera, A.H. Lin, G. Kenis, E. Bosmans, D. van Bockstaele, and M. Maes Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio J. Clin. Psychopharmacol. 21 2001 199 206
73. M. Maes, G. Kenis, M. Kubera, M. De Baets, H. Steinbusch, and E. Bosmans The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway Int. Immunopharmacol. 5 2005 609 618
74. C. Roumestan, A. Michel, F. Bichon, K. Portet, M. Detoc, C. Henriquet, D. Jaffuel, and M. Mathieu Antiinflammatory properties of desipramine and fluoxetine Respir. Res. 3 2007 8 35
75. M. Kubera, K. Curzytek, M. Majewska-Szczepanik, M. Szczepanik, K. Marcińska, W. Ptak, M. Leśkiewicz, M. Maes, A. Basta-Kaim, B. Budziszewska, J. Detka, W. Duda, and W. Lasoń Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction Pharmacol. Rep. 64 2012 714 722
76. A.M. Genaro, V.A. Edgar, and L. Sterin-Borda Differential effects of fluoxetine on murine B-cell proliferation depending on the biochemical pathways triggered by distinct mitogens Biochem. Pharmacol. 60 2000 1279 1283
77. M.G. Frank, S.E. Hendricks, D.R. Johnson, J.L. Wieseler, and W.J. Burke Antidepressants augment natural killer cell activity: in vivo and in vitro Neuropsychobiology 39 1999 18 24
78. S.C. Dulawa, K.A. Holick, B. Gundersen, and R. Hen Effects of chronic fluoxetine in animal models of anxiety and depression Neuropsychopharmacology 29 2004 1321 1330
79. L.M. Koran, J.W. Cain, R.A. Dominguez, A.J. Rush, and S. Thiemann Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? Am. J. Psychiatry 153 1996 1450 1454